MSP Recovery’s Claims Dismissed in Fresenius GranuFlo/NaturaLyte MDL

  • Order

BOSTON — A Massachusetts federal judge has dismissed a third-party payor assignee’s claims accusing Fresenius of failing to warn that its dialysis product GranuFlo can cause heart attacks, ruling that they are untimely.

In a Sept. 7 order, Judge Nathaniel M. Gorton of the U.S. District Court for the District of Massachusetts ruled that MSP Recovery Inc. is not entitled to class action tolling because it failed to establish that it is a member of an original putative class in the Fresenius GranuFlo/NaturaLyte MDL.

Medicare payers, first-tier, downstream, and related entities assigned MSP Recovery the right to recover direct economic …


HarrisMartin's MDL Conference: Uber Litigation and Other Mass Tort Updates

September 27, 2023 - Lexington, KY
21c Museum Hotel Lexington


HarrisMartin’s Benzene and Toxic Tort Litigation Conference: Recent Developments and Future Trends

December 01, 2023 - Charleston, SC
The Charleston Place